ManishaCBalwaniMD
Medical Genetics • New York, NYClinical Genetics
Associate Professor, Genetics & Genomic Sciences, Icahn School of Medicine
Dr. Balwani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1184 Fifth Avenue
2ND floor
New York, NY 10029Phone+1 212-241-0915Fax+1 212-426-9065
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Medical Genetics and Genomics, 2003 - 2006
Zucker School of Medicine at Hofstra/Northwell at Forest Hills HospitalResidency, Internal Medicine, 2000 - 2003
Topiwala National Medical CollegeClass of 1997
Certifications & Licensure
NY State Medical License 2006 - 2025- American Board of Medical Genetics and Genomics Clinical Genetics
Clinical Trials
- Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact Start of enrollment: 2012 Jul 01
- Oral Iron for Erythropoietic Protoporphyrias Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- Reply to: "Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations"?Matthew Surface, Manisha Balwani, Cheryl Waters, Alexander Haimovich, Ziv Gan-Or
Movement Disorders. 2022-08-01 - 103 citationsAcute Hepatic Porphyrias: Recommendations for Evaluation and Long Term ManagementManisha Balwani, Bruce Wang, Karl E. Anderson, Joseph R. Bloomer, D. Montgomery Bissell
Hepatology. 2017-10-01 - 109 citationsThe incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.Barry E. Rosenbloom, Manisha Balwani, Jeff M. Bronstein, Edwin H. Kolodny, Swati Sathe
Blood Cells, Molecules & Diseases. 2011-01-15
Press Mentions
New Four-Year, $3.26 Million Grant from the National Institute of Neurological Disorders and Stroke Establishes the Mount Sinai Center for Undiagnosed DiseasesSeptember 17th, 2024- Dersimelagon Increases Duration of Symptom-Free Sunlight Exposure in Erythropoietic Protoporphyria: NEJMApril 20th, 2023
- Dersimelagon Beneficial for Erythropoietic, X-linked ProtoporphyriaApril 13th, 2023
- Join now to see all
Other Languages
- Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
